|
|
Angiogenesis Inhibitors
Links to news articles on
Angiogenesis Inhibitors
.
Playing Catch-up -- Mar 28, 2006
...demonstrated that cutting off the blood supply to dangerous cells can impede cancer progression), the pipeline is full of new angiogenesis inhibitors, each of ... American Enterprise Institute,
Forecasts for the Approval of Several more Angiogenesis Inhibitors ... -- Mar 14, 2006
Angiogenesis inhibitors have interested cancer researchers since 1971, when Judah Folkman demonstrated that tumor growth depends on angiogenesis. ... Business Wire (press release),
The Four Major Cancer Markets, Which Include Colorectal, Prostate ... -- Mar 2, 2006
...the most effective at treating later-stage prostate cancer and are ... However, with the looming approval of vaccines, angiogenesis inhibitors, and increased use ... Genetic Engineering News,
Nereus Raises $18.3M for Cancer Trials -- Mar 7, 2006
...blood flow has been successfully demonstrated by angiogenesis inhibitors such as ... involves highly selective NFkB modulators for cancer, inflammatory diseases ... PharmaLive.com (press release),
FDA Approves ERBITUX(R) (Cetuximab) for Treatment of Head and Neck ... -- Mar 1, 2006
...with RT in patients with head and neck cancer were mucositis (6 ... research and development programs include growth factor blockers and angiogenesis inhibitors. ... Genetic Engineering News,
FDA Approves ERBITUX(R) (Cetuximab) for Treatment of Head and Neck ... -- Mar 1, 2006
RT in patients with head and neck cancer weremucositis (6 ... Company's research and development programs includegrowth factor blockers and angiogenesis inhibitors. ... Finanzen.net,
TODAY ON PHARMALIVE.COM -- Mar 3, 2006
...may provide a new treatment for these desperately ill cancer patients. ... to highlight exciting new research and development of angiogenesis inhibitors and growth ... PharmaLive.com (press release),
CancerVax Files IND for Novel Anti-Angiogenic Antibody D93 -- Mar 1, 2006
Its mechanism of action differs from other angiogenesis inhibitors that are being evaluated ... in animal models of colon, melanoma, lung and breast cancer tumors. ... Market Wire (press release)
New hope for womb disease sufferers -- Mar 6, 2006
Endostatin or other angiogenesis inhibitors could be one of these approaches.". ... Phase one endostatin cancer trials had already been completed, so data was ... Daily Mail - UK,
CancerVax seeks approval to advance anticancer drug into clinic -- Mar 2, 2006
...and inhibit tumor growth in in vivo models of several types of cancer. ... D93's mechanism of action differs from other angiogenesis inhibitors that are being ... Pharmaceutical Business Review
Several Additional Angiogenesis Inhibitors are Expected to Reach ... -- 25 Jan 2006
Angiogenesis inhibitors have interested cancer researchers since 1971, when Judah Folkman demonstrated that tumor growth depends on angiogenesis. ... Genetic Engineering News,
ImClone Systems Engages Lazard to Review Strategic Alternatives ... -- Jan 24, 2006
...developing novel oncology therapeutics to benefit patients with cancer.". ... and development programs include growth factor blockers and angiogenesis inhibitors. ... Genetic Engineering News,
Drug Combination Shows Promise for Treatment of Advanced ... -- Jan 19, 2006
...an estimated 3,000-5,000 new diagnoses of neuroendocrine cancer every year ... replaced by a newer generation of more potent, less toxic angiogenesis inhibitors. ... AScribe
Drug Combination Shows Promise for Treatment of Advanced ... -- Jan 19, 2006
...be replaced by a newer generation of more potent, less toxic angiogenesis inhibitors. ... Dana-Farber Cancer Institute (http://www.dana-farber.org) is a principal ... Newswise (press release)
New Report Reveals Trends in Cancer Treatment and Emerging ... -- Jan 11, 2006
...the most effective at treating later-stage prostate cancer and are ... However, with the looming approval of vaccines, angiogenesis inhibitors, and increased use ... Yahoo! News (press release)
McDermott´s 2005 Top 10 Life Science Decisions -- Jan 10, 2006
...finasteride but failed to demonstrate its efficacy in treating prostrate cancer. ... that Merck tested (in vitro and in vivo) for use as angiogenesis inhibitors. ... Mondaq News Alerts,
Targeted cancer therapies: Another step forward -- Dec 22, 2005
NSCLC and recent US approval for pancreatic cancer, with forecast ... least 168 investigational compounds, constituted by 28% angiogenesis inhibitors, 25% signal ... News-Medical.net,
Targeted cancer therapies: another step forward -- Dec 23, 2005
Signal transduction inhibitors and angiogenesis inhibitors are believed to provide the ... of drugs will result in 'cocktail’ therapies for cancer, which brings ... Pharmaceutical Business Review
Targeted cancer therapies: another step forward -- 23 Dec 2005
Signal transduction inhibitors and angiogenesis inhibitors are believed to provide the ... of drugs will result in 'cocktail’ therapies for cancer, which brings ... Pharmaceutical Business Review
Targeted cancer therapies: Another step forward -- Dec 22, 2005
NSCLC and recent US approval for pancreatic cancer, with forecast ... least 168 investigational compounds, constituted by 28% angiogenesis inhibitors, 25% signal ... News-Medical.net,
ImClone Systems Issues Statement Regarding Swissmedic Approval of ... -- Dec 22, 2005
...or increased survival with ERBITUX in metastatic colorectal cancer patients ... and development programs include growth factor blockers and angiogenesis inhibitors. ... Business Wire (press release),
ImClone Systems Issues Statement Regarding Swissmedic Approval of ... -- Dec 22, 2005
...of ERBITUX for the treatment of colorectal cancer isbased on ... and developmentprograms include growth factor blockers and angiogenesis inhibitors.ImClone Systems ... Finanzen.net,
EntreMed and Affymax Present Preclinical Data for Novel ... -- Dec 13, 2005
...(Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, and Affymax, Inc., a ... PR Newswire (press release),
Heralded cancer drug a nimble weapon against other diseases -- Dec 18, 2005
...of colon cancers. Scores of other angiogenesis inhibitors are now being studied for cancer therapy. Angiogenesis inhibitors are ... Boston Globe,
New Products and Line Extensions are the Contributing Factors to ... -- Dec 20, 2005
...the most effective at treating later-stage prostate cancer and are ... However, with the looming approval of vaccines, angiogenesis inhibitors, and increased use ... Business Wire (press release),
Cancer Treatment Market for VEGF Inhibitors to Reach $5.3 Billion ... -- Nov 29, 2005
Angiogenesis inhibitors such as Avastin have been studied, first in the laboratory and ... for three decades with the hope they might prevent the growth of cancer. ... SeniorJournal.com,
Low-Dose Chemotherapy Plus Antiangiogenesis Slows Advanced Cancer -- Dec 8, 2005
Where the chemotherapy attacks and kills the cancer cells, angiogenesis inhibitors prevent the growth of new blood vessels, which feed the tumor. ... Ivanhoe,
New treatment for breast cancer studied -- Dec 8, 2005
...in low, frequent doses, might partially shrink breast tumors when given concurrently with angiogenesis inhibitors. Dana-Farber Cancer Institute researchers in ... United Press International
Bausch & Lomb Licenses Novel Compounds From Cephalon for ... -- Dec 1, 2005
...in evaluating the therapeutic potential of small-molecule angiogenesis inhibitors for the ... of angiogenesis is a common goal in both cancer research and in these ... PharmaLive.com (press release),
(PRN) - Brookstone Announces Third Quarter 2005 Financial Results ... -- Dec 13, 2005
...[+]. (PRN) - EntreMed and Affymax Present Preclinical Data for Novel Angiogenesis Inhibitors ... [+. ... [+]. (PRN) - Parents of Children with Cancer Suffer Post ... Bolsamania.com,
EntreMed Receives Composition of Matter Patent Claims for 2ME2 -- Dec 7, 2005
...for its key product candidates, to strengthen its position in next generation antiproliferative and angiogenesis inhibitors for the treatment of cancer, and to ... PR Newswire (press release),
Biomira's Phase 2 Lung Cancer Vaccine Trial Shows No Safety ... -- Nov 20, 2005
We are The Cancer Vaccine People ... product candidates in four areas -- monoclonal antibodies, therapeutic vaccines, immunocytokines and angiogenesis inhibitors. ... Medical News Today (press release),
MethylGene Updates on Multi-Targeted Kinase Inhibitor Program ... -- Nov 16, 2005
...oral anti-tumour efficacy when compared to several competitor anti-angiogenesis inhibitors which are ... "All of these targets play a role in cancer and the ... CCNMatthews (press release),
ERBITUX(R) Data on Locoregional Control and Overall Survival in ... -- Nov 16, 2005
...or increased survival with ERBITUX in metastatic colorectal cancer patients ... and development programs include growth factor blockers and angiogenesis inhibitors. ... Genetic Engineering News,
ERBITUX(R) Data on Locoregional Control and Overall Survival in ... -- Nov 16, 2005
...of ERBITUX for the treatment of colorectal cancer isbased on ... research and development programs includegrowth factor blockers and angiogenesis inhibitors. ... Finanzen.net,
Two New Patents Strengthen EntreMed's Position in Antiangiogenic ... -- Oct 20, 2005
...of small molecule drugs for the treatment of cancer and inflammatory ... our lead compound, and strengthen the position of other angiogenesis inhibitors in our ... PR Newswire (press release),
Cancer Researcher Receives Coleman Chair -- Oct 20, 2005
...malignancies. Dr. Remick's research focuses on the clinical development of new cancer treatments, such as angiogenesis inhibitors. In ... PR Newswire (press release),
Sales of Major Players in the Prostrate Cancer Market have been ... -- 21 Nov 2005
...in other tumors. However, opinion leaders have identified angiogenesis inhibitors to be the most promising for prostate cancer. Business Wire (press release),
Biomira's Phase 2 Lung Cancer Vaccine Trial Shows No Safety ... -- Nov 20, 2005
We are The Cancer Vaccine People ... product candidates in four areas -- monoclonal antibodies, therapeutic vaccines, immunocytokines and angiogenesis inhibitors. ... Medical News Today (press release),
MethylGene Updates on Multi-Targeted Kinase Inhibitor Program ... -- Nov 16, 2005
...oral anti-tumour efficacy when compared to several competitor anti-angiogenesis inhibitors which are ... "All of these targets play a role in cancer and the ... CCNMatthews (press release),
ERBITUX(R) Data on Locoregional Control and Overall Survival in ... -- Nov 16, 2005
...or increased survival with ERBITUX in metastatic colorectal cancer patients ... and development programs include growth factor blockers and angiogenesis inhibitors. ... Genetic Engineering News,
ERBITUX(R) Data on Locoregional Control and Overall Survival in ... -- Nov 16, 2005
...of ERBITUX for the treatment of colorectal cancer isbased on ... research and development programs includegrowth factor blockers and angiogenesis inhibitors. ... Finanzen.net,
Two New Patents Strengthen EntreMed's Position in Antiangiogenic ... -- Oct 20, 2005
...of small molecule drugs for the treatment of cancer and inflammatory ... our lead compound, and strengthen the position of other angiogenesis inhibitors in our ... PR Newswire (press release),
Cancer Researcher Receives Coleman Chair -- Oct 20, 2005
...malignancies. Dr. Remick's research focuses on the clinical development of new cancer treatments, such as angiogenesis inhibitors. In ... PR Newswire (press release),
|
|
|
|
More information on
Angiogenesis Inhibitors from the National Cancer Institute
One promising avenue of cancer research is the study of a group of compounds called angiogenesis inhibitors. These are drugs that block the development of new blood vessels, a process known as angiogenesis.
By blocking the development of new blood vessels, researchers hope to cut off the tumor's supply of oxygen and nutrients. This in turn might stop the tumor from growing and spreading to other parts of the body.
More from the National Cancer Institute
|
|
